At the agency’s public meeting on the proposed PreCheck framework, companies said reductions in inspection-related delays could significantly de-risk and reduce timelines.
The Zhunan facility upgrade will add high-potency, advanced delivery liquid-filled capsule capabilities for complex pharmaceutical ingredients by early 2026.
